Since its emergence in December 2019, the world has been dealing with COVID-19, which was officially declared a global pandemic by the World Health Organization in March. As the virus continues to spread and infect people worldwide, research is constantly underway to develop new antiviral drugs to help treat patients.
On October 22, 2020, the FDA approved the first antiviral drug for treating COVID-19, called Remdesivir. Remdesivir works by targeting RNA polymerase and therefore inhibiting the viral RNA replication of SARS-CoV-2,. This antiviral holds a great deal of promise and is an exciting discovery in the field of medicine.
[Please complete our feedback form]